Mar 2, 2023 | Insights
Where is the Digital Therapeutics (DTx) market headed? by Tarek Milla, March 2, 2023 Recently, it has become evident that Digital Therapeutics (DTx) are occupying a prominent place in the Digital Health environment, given that they present effective solutions, based...
Feb 16, 2023 | Corporate
The promising sector of Digital Therapeutics (DTx) by Patricia Domínguez, February 16, 2023 Digital Therapeutics are software based on scientific evidence, aimed at preventing, managing, and treating diseases. The goal of these tools is to improve health outcomes in...
Feb 8, 2023 | Corporate
Interview with our Chief Business Development Officer, Elli Ghozzati by Elli Ghozzati, February 8, 2023 Elli Ghozzati is the current Chief Business Development Officer at Persei vivarium, a Digital Health company specialized in clinical data management for better...
Feb 1, 2023 | Events
Persei vivarium presents its approach to Digital Therapeutics (DTx) at the MAD e-Health event by Tarek Milla, February 1, 2023 The 9th MAD e-Health event was held on January 27th, gathering the benchmark companies in the health and biotech sectors to share the most...
Feb 23, 2022 | Insights
Digital Therapeutics (DTx): What role do they play and what are the current market projections? by Tarek Milla, February 23, 2022 The promotion of the digitalization of health over the past months as a result of the COVID-19 pandemic has made Digital Health and...